These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30247905)

  • 1. Discovery and Optimization of Novel Hydrogen Peroxide Activated Aromatic Nitrogen Mustard Derivatives as Highly Potent Anticancer Agents.
    Chen W; Fan H; Balakrishnan K; Wang Y; Sun H; Fan Y; Gandhi V; Arnold LA; Peng X
    J Med Chem; 2018 Oct; 61(20):9132-9145. PubMed ID: 30247905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes.
    Chen W; Balakrishnan K; Kuang Y; Han Y; Fu M; Gandhi V; Peng X
    J Med Chem; 2014 Jun; 57(11):4498-510. PubMed ID: 24801734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
    Singh RK; Kumar S; Prasad DN; Bhardwaj TR
    Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the N-lost drugs melphalan and bendamustine: synthesis and cytotoxicity of a new set of dendrimer-drug conjugates as tumor therapeutic agents.
    Scutaru AM; Wenzel M; Scheffler H; Wolber G; Gust R
    Bioconjug Chem; 2010 Oct; 21(10):1728-43. PubMed ID: 20849062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal esters of the aromatic nitrogen mustard 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoic acid (2-PHE-BU): synthesis and in-vivo biological evaluation.
    Papaconstantinou IC; Fousteris MA; Koutsourea AI; Pairas GN; Papageorgiou AD; Nikolaropoulos SS
    Anticancer Drugs; 2013 Jan; 24(1):52-65. PubMed ID: 23187313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen peroxide inducible DNA cross-linking agents: targeted anticancer prodrugs.
    Kuang Y; Balakrishnan K; Gandhi V; Peng X
    J Am Chem Soc; 2011 Dec; 133(48):19278-81. PubMed ID: 22035519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5'-GNC preference for mustard cross-linking is preserved in a restriction fragment.
    Millard JT; Luedtke NW; Spencer RJ
    Anticancer Drug Des; 1996 Sep; 11(6):485-92. PubMed ID: 8836112
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake.
    Hagos Y; Hundertmark P; Shnitsar V; Marada VV; Wulf G; Burckhardt G
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F330-8. PubMed ID: 25477469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced hydrolytic stability and water solubility of an aromatic nitrogen mustard by conjugation with molecular umbrellas.
    Vijayaraghavan S; Jing B; Vrablik T; Chou TC; Regen SL
    Bioconjug Chem; 2003; 14(3):667-71. PubMed ID: 12757393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic cytogenetic and antineoplastic effects by the combined action of esteric steroidal derivatives of nitrogen mustards.
    Mourelatos C; Nikolaropoulos S; Fousteris M; Pairas G; Argyraki M; Kareli D; Dafa E; Mourelatos D; Lialiaris T
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):558-62. PubMed ID: 22300530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs.
    More GS; Thomas AB; Chitlange SS; Nanda RK; Gajbhiye RL
    Anticancer Agents Med Chem; 2019; 19(9):1080-1102. PubMed ID: 30834842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
    Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
    J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatic nitrogen mustard-based prodrugs: activity, selectivity, and the mechanism of DNA cross-linking.
    Chen W; Han Y; Peng X
    Chemistry; 2014 Jun; 20(24):7410-8. PubMed ID: 24806710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivatives of nitrogen mustard anticancer agents with improved cytotoxicity.
    Antoni F; Bernhardt G
    Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000366. PubMed ID: 33283341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach for evaluating in vivo anti-leukemic activity using the SCE assay. An application on three newly synthesised anti-tumour steroidal esters.
    Karayianni V; Mioglou E; Iakovidou Z; Mourelatos D; Fousteris M; Koutsourea A; Arsenou E; Nikolaropoulos S
    Mutat Res; 2003 Feb; 535(1):79-86. PubMed ID: 12547285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of mustard derivatives of thymine.
    Hadj-Bouazza A; Teste K; Colombeau L; Chaleix V; Zerrouki R; Kraemer M; Sainte Catherine O
    Nucleosides Nucleotides Nucleic Acids; 2008 May; 27(5):439-48. PubMed ID: 18569783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
    Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A
    Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
    Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
    J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
    Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
    J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.